Literature DB >> 16916864

In vitro susceptibility of Bartonella species to 17 antimicrobial compounds: comparison of Etest and agar dilution.

Christina Dörbecker1, Anna Sander, Karin Oberle, Tanja Schülin-Casonato.   

Abstract

OBJECTIVES: In vitro susceptibility testing of 31 Bartonella spp. strains including 21 Bartonella henselae isolates was performed for 17 antimicrobial agents (telithromycin, four macrolides, five fluoroquinolones, five aminoglycosides, doxycycline and rifampicin).
METHODS: MICs were determined by agar dilution and Etest using chocolate agar containing 5% defibrinated sheep blood as assay medium. Longer incubation periods of 3-5 days in a humid atmosphere with 5% CO(2) were required until bacterial growth became visible and MICs could be read.
RESULTS: The ketolide telithromycin was the most active agent exhibiting the lowest MICs. The Bartonella spp. were also highly susceptible to macrolides, particularly clarithromycin, and to doxycycline and rifampicin, with MICs of <or=0.12 mg/L. Gatifloxacin, gemifloxacin and moxifloxacin were the most potent fluoroquinolones, with MICs ranging from 0.06 to 2 mg/L. Netilmicin was the most active agent among the aminoglycosides. Etest MICs correlated well with MICs determined by agar dilution.
CONCLUSIONS: Telithromycin, macrolides, doxycycline and rifampicin were the most effective agents against Bartonella spp. Our data confirm that Etest may be a reliable method for determining susceptibility of Bartonella spp.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916864     DOI: 10.1093/jac/dkl341

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Granulomatous hepatitis due to Bartonella henselae infection in an immunocompetent patient.

Authors:  Thomas R VanderHeyden; Sherri L Yong; Edward B Breitschwerdt; Ricardo G Maggi; Amanda R Mihalik; Jorge P Parada; Claus J Fimmel
Journal:  BMC Infect Dis       Date:  2012-01-23       Impact factor: 3.090

2.  Unusual retinal manifestations of cat scratch disease.

Authors:  Antonio Pinna; Ester Puglia; Stefano Dore
Journal:  Int Ophthalmol       Date:  2011-01-26       Impact factor: 2.031

3.  Studies on the antimicrobial properties of N-acylated ciprofloxacins.

Authors:  Ryan Cormier; Whittney N Burda; Lacey Harrington; Jordan Edlinger; Karthik M Kodigepalli; John Thomas; Rebecca Kapolka; Glen Roma; Burt E Anderson; Edward Turos; Lindsey N Shaw
Journal:  Bioorg Med Chem Lett       Date:  2012-07-01       Impact factor: 2.823

4.  Cryptogenic hepatitis patients have a higher Bartonella sp.-DNA detection in blood and skin samples than patients with non-viral hepatitis of known cause.

Authors:  Marina Rovani Drummond; Luciene Silva Dos Santos; Renata Soalheiro Fávaro; Raquel Silveira Bello Stucchi; Ilka de Fátima Santana Ferreira Boin; Paulo Eduardo Neves Ferreira Velho
Journal:  PLoS Negl Trop Dis       Date:  2022-07-18

5.  Antibiotic Susceptibility of Bartonella Grown in Different Culture Conditions.

Authors:  Shiva Kumar Goud Gadila; Monica E Embers
Journal:  Pathogens       Date:  2021-06-08

6.  Chronic Lyme Disease and Co-infections: Differential Diagnosis.

Authors:  Walter Berghoff
Journal:  Open Neurol J       Date:  2012-12-28

7.  Identification of Bartonella henselae in the liver of a thoroughbred foal with severe suppurative cholangiohepatitis.

Authors:  E L Setlakwe; R Sweeney; J B Engiles; A L Johnson
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.